Actually, the commonly used chemotherapy drug methotrexate (MTX) targets DHFR to block THF production to inhibit rapidly proliferating tumor cells [175]; however, given its toxicity and resistance, there has been a search for new DHFR inhibitors. This evidence concerns the gene DHFR and neoplasm.